InsidersTradesSigma
Follow the 康美药业 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 康美药业 has recorded 1 reports. Market capitalisation: €18.7bn. The latest transaction was filed on 14 February 2022 (Sale). Among the most active insiders: 李建华. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
康美药业是一家专注于医药和医疗保健行业的中国公司。该公司在上海证券交易所（XSHG）上市。